Lhe Doctolib group, a French heavyweight in medical appointment booking and teleconsultation, announced on Tuesday March 15 a fundraising of 500 million euros which will be used to create 3,500 jobs within five years. This financing operation allows Doctolib to become neither more nor less than the most valued start-up in France, underlines The world. “We have obtained funding of 500 million euros,” says Stanislas Niox-Chateau, president of Doctolib, on the group’s LinkedIn page.
This fundraiser, which “values the company he founded in 2013 at 5.8 billion euros”, should “allow him to create 3,500 new jobs, in 30 cities in France, Germany and Italy. over the next five years,” he adds.
The windfall comes mainly from the French fund Eurazeo and the public investment bank Bpifrance, already present in the capital since 2017 and which remain the main shareholders of Doctolib, behind its managers and employees, specified Stanislas Niox-Chateau to Agence France Hurry.
READ ALSOHealth start-up: what’s up, doctor?
A profitability target for 2024
Hailing “a mark of confidence for the next ten years”, he hopes that his company will finally achieve profitability much sooner, setting “the target for 2024 or 2025”. Which will not be easy, because “every euro we have, we reinvest it”, he assures us, listing the ongoing software developments for doctors, nurses and liberal physiotherapists, but also for hospitals, all of which are due to be completed this year.
Not to mention other “secure instant messaging” projects, exchange of medical documents and electronic prescription, but a priori no new acquisition planned on or outside its three current markets.
–
